Our products comprise the medication needed to relieve symptoms and significantly improve the quality of life, as well as medication that is primarily used in critical, life-threatening situations. That is why we maintain constant communication with medical specialists and focus on the real needs in medical practice to develop products in line with actual clinical requirements.
Highest quality standards, delivery reliability and a strong drive to excel as a team are fundamentally important to us. We act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. We share the responsibility for the smooth functioning of medical measures at the decisive moment. Whether owner or team members - at AMOMED Pharma, we are fully aware of the importance of our actions and are deeply committed to the far-reaching aspect of our work.
CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification to modulate systemic inflammation - with the goal of preventing or treating multi-organ failure in life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption.